Rudo Mashindi, MD
Family Medicine · Greenfield, INNPI 1447694468
Payments from drug & device makers
Across 297 payments — averaging $17.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$865
- Novo Nordisk$628
- Lilly USA, LLC$488
- Pfizer$467
- GSK$255
- AbbVie$232
- plus $2K from 28 others
What the payments were for
- Food & beverage$5,122100%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 31 | $865 |
| Novo Nordisk | 47 | $628 |
| Lilly USA, LLC | 34 | $488 |
| Pfizer | 33 | $467 |
| GSK | 16 | $255 |
| AbbVie(2 entities) | 11 | $232 |
| Johnson & Johnson | 19 | $219 |
| Arbor Pharmaceuticals, Inc. | 3 | $203 |
| Amgen | 11 | $183 |
| Exact Sciences | 9 | $180 |
| Boehringer Ingelheim | 10 | $169 |
| Otsuka America Pharmaceutical, Inc. | 8 | $167 |
| Novartis | 10 | $165 |
| Astellas Pharma US Inc | 8 | $152 |
| Phathom Pharmaceuticals, Inc. | 6 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $105 |
| Axsome Therapeutics, Inc. | 5 | $94 |
| Neos Therapeutics, LP | 3 | $59 |
| Amarin Pharma, Inc. | 4 | $56 |
| Corium, LLC | 2 | $41 |
| Merck | 2 | $33 |
| Abbott | 2 | $31 |
| Sanofi Pasteur Inc. | 2 | $30 |
| Averitas Pharma Inc. | 1 | $24 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Bayer | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Eli Lilly | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $14 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIRSUPRA$116
How this compares
$5,138 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 89 | $99,742 |
| MounjaroTirzepatide | 33 | $49,053 |
| TrulicityDulaglutide | 20 | $46,179 |
| JardianceEmpagliflozin | 29 | $34,272 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $33,807 |
| JanuviaSitagliptin Phosphate | 28 | $33,062 |
| XareltoRivaroxaban | 23 | $30,025 |
| OzempicSemaglutide | 28 | $27,392 |
| RybelsusSemaglutide | 16 | $19,970 |
| FarxigaDapagliflozin Propanediol | 27 | $18,423 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 16 | $17,404 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 71 | $15,895 |
| InvokanaCanagliflozin | 14 | $14,718 |
| Repatha SureclickEvolocumab | 17 | $12,964 |
| MyrbetriqMirabegron | 22 | $11,295 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Abrysvo, Paxlovid | $467 | $110,406125 claims |
| Lilly USA, LLCMounjaro, Trulicity | $488 | $95,23253 claims |
| GSKTrelegy Ellipta, Shingrix, Breo Ellipta | $255 | $58,527129 claims |
| Novo NordiskOzempic, Rybelsus | $628 | $47,36244 claims |
| Johnson & JohnsonXarelto, Invokana | $219 | $44,74337 claims |
| Boehringer IngelheimJardiance | $169 | $34,27229 claims |
| MerckJanuvia | $33 | $33,06228 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $865 | $27,43441 claims |
| Astellas Pharma US IncMyrbetriq | $152 | $11,29522 claims |
| NovartisEntresto | $165 | $8,08213 claims |
| AbbVieSynthroid | $232 | $1,64732 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Greenfield
- Talessa PowellGreenfield$1.4M
- Thomas O'ConnorGreenfield$228K
- Blair BrengleIndianapolis$10.6M
- Laura HelmanMishawaka$4M
- J Christopher SartoreEvansville$3.9M
- Hubert ReyesEvansville$3.2M
- David SchultzEvansville$3M
- Steven SmithIndianapolis$2.5M
- Renee Michelle GalenNewburgh$2.1M
- Eric HewittAvon$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.